Skip to Content

Rapivab Side Effects

Generic Name: peramivir

Note: This page contains side effects data for the generic drug peramivir. It is possible that some of the dosage forms included below may not apply to the brand name Rapivab.

For the Consumer

Applies to peramivir: intravenous solution, solution iv (infusion)

As well as its needed effects, peramivir (the active ingredient contained in Rapivab) may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking peramivir, check with your doctor or nurse immediately:

Rare
  • Blistering, peeling, or loosening of the skin
  • chills
  • cough
  • diarrhea
  • fever
  • itching
  • joint or muscle pain
  • red, irritated eyes
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • unusual tiredness or weakness
Incidence not known:
  • Confusion as to time, place, or person
  • holding false beliefs that cannot be changed by fact
  • red skin lesions, often with a purple center
  • seeing, hearing, or feeling things that are not there
  • unusual excitement, nervousness, or restlessness

Minor Side Effects

Some peramivir side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Less common:
  • Blurred vision
  • difficulty having a bowel movement (stool)
  • dizziness
  • headache
  • nervousness
  • pounding in the ears
  • slow or fast heartbeat
  • trouble sleeping

For Healthcare Professionals

Applies to peramivir: intravenous solution

Cardiovascular

Common (1% to 10%): Hypertension[Ref]

Gastrointestinal

Common (1% to 10%): Constipation, diarrhea[Ref]

Hepatic

Common (1% to 10%): AST increased, ALT greater than 2.5 times the upper limit of normal (ULN)[Ref]

Hypersensitivity

Postmarketing reports: Steven-Johnson Syndrome, exfoliative dermatitis, rash[Ref]

Immunologic

Common (1% to 10%): Neutrophils less than 1 x 10(9)/L[Ref]

Metabolic

Common (1% to 10%): Serum glucose greater than 160 mg/dL[Ref]

Musculoskeletal

Common (1% to 10%): Creatine phosphokinase 6 x ULN or greater[Ref]

Psychiatric

Common (1% to 10%): Insomnia
Postmarketing reports: Delirium, hallucination[Ref]

References

1. "Product Information. Rapivab (peramivir)." BioCryst Pharmaceuticals Inc, Durham, NC.

It is possible that some side effects of Rapivab may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide